2020
DOI: 10.1007/s43032-020-00212-8
|View full text |Cite
|
Sign up to set email alerts
|

Regulation of Uterine Spiral Artery Remodeling: a Review

Abstract: Extravillous trophoblast remodeling of the uterine spiral arteries is essential for promoting blood flow to the placenta and fetal development, but little is known about the regulation of this process. A defect in spiral artery remodeling underpins adverse conditions of human pregnancy, notably early-onset preeclampsia and fetal growth restriction, which result in maternal and fetal morbidity and mortality. Many in vitro studies have been conducted to determine the ability of growth and other factors to stimul… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

1
40
0

Year Published

2020
2020
2024
2024

Publication Types

Select...
6
3

Relationship

0
9

Authors

Journals

citations
Cited by 58 publications
(41 citation statements)
references
References 181 publications
1
40
0
Order By: Relevance
“…Although anti-miR-210-3p was able to increase cell migration, invasion and EVT outgrowth, it only significantly increased the branching points at 48 h and did not significantly increase enEVT marker mRNA levels. Since many factors are involved in promoting spiral artery remodeling [44,45], it is likely that partial inhibition of endogenous miR-210-3p alone is insufficient to increase angiogenic potential and enEVT marker expression.…”
Section: Discussionmentioning
confidence: 99%
“…Although anti-miR-210-3p was able to increase cell migration, invasion and EVT outgrowth, it only significantly increased the branching points at 48 h and did not significantly increase enEVT marker mRNA levels. Since many factors are involved in promoting spiral artery remodeling [44,45], it is likely that partial inhibition of endogenous miR-210-3p alone is insufficient to increase angiogenic potential and enEVT marker expression.…”
Section: Discussionmentioning
confidence: 99%
“…The diagnostic criteria for PE is systolic blood pressure (SBP) ≥ 140 mm Hg and/or diastolic blood pressure (DBP) ≥ 90 mm Hg, accompanied by proteinuria and/or impairment of maternal vital organ function, or fetal growth restriction 2 . During the early stages of normal pregnancy, the extravillous trophoblasts gradually invade and replace the vascular smooth muscle cells and endothelial cells in the uterine spiral arteries, a process known as spiral artery remodelling 3 . The pathogenesis of PE is characterized by the reduction of placental perfusion caused by shallow placental implantation, which is a consequence of disorders in spiral artery remodelling.…”
Section: Introductionmentioning
confidence: 99%
“…Complications of anticoagulant therapy in pregnancy include embryopathy (nasal hypoplasia, spotted epiphyses), CNS abnormalities (Dandy-Walker syndrome, visual atrophy), fetal bleeding, hemorrhagic manifestations, skin allergies, thrombocytopenia and osteoporosis [60][61][62][63][64][65][66][67][68][69][70][71][72].…”
Section: When Will We Check a Patient For Aplsmentioning
confidence: 99%